Pirogov Russian National Research Medical University
Moscow, 117997, Russia
Location status: Recruiting
NCT Number: NCT03041805
The aim of the study is to make a validation of Caprini score in patients undergoing varicose veins surgery, especially endovascular procedures (endovascular laser treatment - EVLT, radiofrequency ablation - RFA, ultrasound-guided foam sclerotherapy - USFS) and to identify patients with elevated risk of postoperative venous thromboembolism (VTE) who will benefit from prophylactic anticoagulation.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Moscow, 117997, Russia
Location status: Recruiting
A prospective cohort study based on the platform of Ongoing Registry of Treatment of Chronic Venous Diseases (NCT03035747). The study will enrol adult patients undergoing any kind of varicose veins surgery with and without any prophylaxis. The patients should be examined for venous thromboembolic complications during 2-4 weeks after the procedure with mandatory duplex ultrasound.
The study will provide following information:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Endovenous laser treatment of great saphenous vein, small saphenous vein, accessorial saphenous vein with different laser wavelength and any bare type
Radiofrequency ablation of great saphenous vein, small saphenous vein, accessorial saphenous vein with ClosureFast technique
Ultrasound guided foam sclerotherapy of great saphenous vein, small saphenous vein, accessorial saphenous vein with polidocanol or tetradecyl sulphate of any concentration
High ligation and stripping of great saphenous vein, small saphenous vein, accessorial saphenous vein
Miniphlebectomy of any varicose veins under local, regional or general anaesthesia
Foam or liquid sclerotherapy of any varicose veins with polidocanol or tetradecyl sulphate of any concentration
Graduated compression stockings may be used after procedure by the decision of the doctor
Low-molecular-weight heparin may be used after procedure by the decision of the doctor
Time frame: 0-4 weeks after procedure
symptomatic or asymptomatic, confirmed by instrumental diagnostics
Time frame: 0-4 weeks after procedure
symptomatic deep vein thrombosis confirmed by duplex ultrasound
Time frame: 0-4 weeks after procedure
symptomatic pulmonary embolism confirmed by perfusion isotope scanning or CT pulmonary angiography
Time frame: 2-4 weeks after procedure
asymptomatic DVT revealed by duplex ultrasound
Time frame: 0-4 weeks after procedure
EHIT revealed by duplex ultrasound
Time frame: 0-4 weeks after procedure
Fatal bleeding, and/or symptomatic bleeding in a critical area or organ, such as intracranial, intraspinal, intraocular, retroperitoneal, intraarticular or pericardial, or intramuscular with compartment syndrome, and/or bleeding causing a fall in haemoglobin level of 20 g/L or more, or leading to transfusion of two or more units of whole blood or red cells.
Time frame: 0-4 weeks after procedure
any non-major bleeding need for treatment or intervention
Time frame: 0-4 weeks after procedure
Contact information is provided by the study sponsor or research team.
Pirogov Russian National Research Medical University
Other
A Prospective Cohort Register Study for Validation of Caprini Score in Patients Undergoing Varicose Vein Surgery
Acronym: CAPSIVS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06494878
Aspirin, Cardiovascular Diseases
Brussels, Belgium
View Trial DetailsNCT06195540
Cardiovascular Diseases, Deep Vein Thrombosis
Agen, France
View Trial DetailsNCT05735639
Cardiovascular Diseases, Embolism and Thrombosis
London, United Kingdom
View Trial DetailsNCT05881798
Cardiovascular Diseases, Deep Vein Thrombosis
Los Angeles, California, United States
View Trial Details